Business
Moderna vaccine shows signs of working in older adults – The Australian Financial Review
The results offer a more complete picture of the vaccine’s safety for a group at increased risk of severe complications from the COVID-19 virus.
Moderna is already testing the higher dose in a large Phase III trial, the final stage before seeking emergency authorisation or approval.
Side effects, which included headache, fatigue, body aches, chills and injection site pain, were deemed mainly mild to moderate.
In at least two cases, however, volunteers had severe reactions.
One developed a grade three fever, which is classified as 102.2 degrees Fahrenheit (39°C) or above, after receiving the lower vaccine dose. Another developed fatigu…
-
Noosa News18 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General18 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
General20 hours agoPerth man charged after investigation into organised crime and tobacco store attacks
-
General10 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging